Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke

L Chen, JE Peters, B Prins, E Persyn, M Traylor… - Nature …, 2022 - nature.com
Stroke is the second leading cause of death with substantial unmet therapeutic needs. To
identify potential stroke therapeutic targets, we estimate the causal effects of 308 plasma …

CD6, a rheostat-type signalosome that tunes T cell activation

CM Gonçalves, SN Henriques, RF Santos… - Frontiers in …, 2018 - frontiersin.org
Following T cell receptor triggering, T cell activation is initiated and amplified by the
assembly at the TCR/CD3 macrocomplex of a multitude of stimulatory enzymes that activate …

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses

SA Chalmers, RA Ramachandran… - The Journal of …, 2022 - Am Soc Clin Investig
T cells are central to the pathogenesis of lupus nephritis (LN), a common complication of
systemic lupus erythematosus (SLE). CD6 and its ligand, activated leukocyte cell adhesion …

La industria biofarmacé utica cubana en el combate contra la pandemia de COVID-19

EMÃ DÃaz, PÃ Rolando, LC Serra - Anales de la Academia de …, 2020 - revistaccuba.sld.cu
La pandemia del nuevo coronavirus ha desafiado la capacidad de respuesta de los
sistemas de salud en la mayorÃa de los paÃses. La estrategia de Cuba ha sido …

Soluble CD5 and CD6: Lymphocytic class I scavenger receptors as immunotherapeutic agents

M Velasco-de Andrés, S Casadó-Llombart, C Català… - Cells, 2020 - mdpi.com
CD5 and CD6 are closely related signal-transducing class I scavenger receptors mainly
expressed on lymphocytes. Both receptors are involved in the modulation of the activation …

[HTML][HTML] Equity and the Cuban National Health System's response to COVID-19

P Mas Bermejo, L Sánchez Valdés… - … de Salud Pública, 2021 - SciELO Public Health
ABSTRACT Cuba's National Health System has managed to guarantee an effective and
equitable response to COVID-19. Universal and free health coverage, based on primary …

CD6 modulates thymocyte selection and peripheral T cell homeostasis

M Orta-Mascaró, M Consuegra-Fernández… - Journal of experimental …, 2016 - rupress.org
The CD6 glycoprotein is a lymphocyte surface receptor putatively involved in T cell
development and activation. CD6 facilitates adhesion between T cells and antigen …

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

U Bughani, A Saha, A Kuriakose, R Nair… - PloS one, 2017 - journals.plos.org
CD6 is associated with T-cell modulation and is implicated in several autoimmune diseases.
We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized …

CD6-mediated inhibition of T cell activation via modulation of Ras

SN Henriques, L Oliveira, RF Santos… - Cell Communication and …, 2022 - Springer
Background CD6 is one of many cell surface receptors known to regulate signal
transduction upon T cell activation. However, whether CD6 mediates costimulatory or …

CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies

L Aragón-Serrano, L Carrillo-Serradell… - International Journal of …, 2023 - mdpi.com
Cancer management still requires more potent and safer treatments, of which
immunomodulatory receptors on the lymphocyte surface have started to show promise in …